MNDY vs ZVRA · P/E 32, rev $1.23B vs P/E 6.3, rev $75.9M
Monday.Com Ltd (MNDY) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
MNDY currently screens at market cap $3.79B and trailing P/E 32.1. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the MNDY and ZVRA stock pages for the full models.
Not investment advice.